SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 124 filers reported holding SAGE THERAPEUTICS INC in Q2 2015. The put-call ratio across all filers is 2.96 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $6,662,000 | +11.0% | 130,472 | +0.1% | 0.01% | +14.3% |
| Q3 2016 | $6,002,000 | +80.9% | 130,334 | +18.4% | 0.01% | +75.0% |
| Q2 2016 | $3,317,000 | +67.5% | 110,084 | +78.3% | 0.00% | +33.3% |
| Q1 2016 | $1,980,000 | -36.7% | 61,752 | +15.2% | 0.00% | -25.0% |
| Q4 2015 | $3,126,000 | +37.6% | 53,624 | -0.1% | 0.00% | +33.3% |
| Q3 2015 | $2,271,000 | -46.0% | 53,671 | -6.9% | 0.00% | -40.0% |
| Q2 2015 | $4,207,000 | +338.2% | 57,631 | +201.6% | 0.01% | +400.0% |
| Q1 2015 | $960,000 | +40.6% | 19,110 | +2.4% | 0.00% | 0.0% |
| Q4 2014 | $683,000 | +24.2% | 18,663 | +6.9% | 0.00% | 0.0% |
| Q3 2014 | $550,000 | – | 17,460 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Finepoint Capital LP | 475,600 | $15,362,000 | 5.31% |
| Integral Health Asset Management, LLC | 412,257 | $13,316,000 | 2.74% |
| Palo Alto Investors LP | 851,409 | $27,501,000 | 2.40% |
| Boxer Capital, LLC | 1,094,000 | $35,336,000 | 2.24% |
| DAFNA Capital Management LLC | 180,306 | $5,824,000 | 1.59% |
| Ikarian Capital, LLC | 250,000 | $8,075,000 | 1.47% |
| Bellevue Group AG | 2,973,178 | $96,034,000 | 1.36% |
| SECTOR GAMMA AS | 118,476 | $3,827,000 | 0.86% |
| Artal Group S.A. | 450,000 | $14,535,000 | 0.78% |
| Diametric Capital, LP | 19,393 | $626,000 | 0.46% |